| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/08/2004 | CN1527822A Thiazole derivatives for treating PPAR related disorders |
| 09/08/2004 | CN1527816A New indole derivatives with 5-HT6 receptor affinity |
| 09/08/2004 | CN1527814A Nitric oxide synthase inhibitor phosphate salt |
| 09/08/2004 | CN1527811A Process for the preparation of (R)-or (S)-aminocarnitine inner salt, the salts and derivatives thereof |
| 09/08/2004 | CN1527723A Methods for treating or preventing skin disorders using CD2-binding agents |
| 09/08/2004 | CN1527710A Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 09/08/2004 | CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications |
| 09/08/2004 | CN1527707A The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 09/08/2004 | CN1527704A Compositions and method of administering tubulin binding agents for the treatment of ocular diseases |
| 09/08/2004 | CN1527670A Aimal growth regulating composition and its prepn and use |
| 09/08/2004 | CN1526442A Solid fermented fungus powder as food and medicine |
| 09/08/2004 | CN1526419A Blood sugar and blood fat reducing composite microbial mineral nutrient liquid and its prepn process |
| 09/08/2004 | CN1526418A Nutrient liquid containing the extract of tiantai lindera leaf |
| 09/08/2004 | CN1526412A Making process of nanometer level pearl powder and shell powder |
| 09/08/2004 | CN1526409A Medicated food for preventing and treating several kinds of diseases such as: alcoholism, fatty liver, diabetes and its making process |
| 09/08/2004 | CN1526391A Composition containing 5-[4-[2-(N-methyl-N-2-pyridyl)amino oxethyl] benzyl] thiazolidine-2, 4-diketone |
| 09/08/2004 | CN1526384A Quickly disintegrated fenofibrate oral prepn |
| 09/08/2004 | CN1526383A Jiafuming and Glibenclamide solid oral preparation and preparing method thereof |
| 09/08/2004 | CN1526379A Sibutramine hydrochloride dripping pill and its prepn |
| 09/08/2004 | CN1165551C Viva pertusa polyose for regulating blood fat and its preparing method |
| 09/08/2004 | CN1165539C Oxazinocarbazoles for the treatment of CNS diseases |
| 09/08/2004 | CN1165537C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists |
| 09/08/2004 | CN1165518C Biocyclic amino acids compound compound as pharmaceutical agents |
| 09/08/2004 | CN1165340C Cartilage/bone inducing materials for reparation |
| 09/08/2004 | CN1165336C Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 09/08/2004 | CN1165318C Health tea for reducing blood fat |
| 09/08/2004 | CN1165314C Use of polylactic mixture in preparation of treatment |
| 09/08/2004 | CN1165312C Hydrosterol composition and use thereof |
| 09/08/2004 | CN1165310C Drug-(combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6- enoic acid and an inhibitor,inducer or substrate of P450 |
| 09/07/2004 | US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
| 09/07/2004 | US6787566 Breakers of advanced glycation endproducts |
| 09/07/2004 | US6787561 Benzimidazole compounds |
| 09/07/2004 | US6787560 Serotonin reuptake inhibitor |
| 09/07/2004 | US6787558 Neuropeptide y receptor antagonists, for treating arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity |
| 09/07/2004 | US6787556 Benzoic acid derivatives for the treatment of diabetes mellitus |
| 09/07/2004 | US6787552 PPAR delta activators |
| 09/07/2004 | US6787551 Thiazolidinedione derivatives and pharmaceutical composition comprising the same |
| 09/07/2004 | US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/07/2004 | US6787549 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder |
| 09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
| 09/07/2004 | US6787538 Hormone replacement therapy; agonists, antagonists; antiestrogens with little to no intrinsic estrogenicity |
| 09/07/2004 | US6787535 Indole derivatives with 5HT6 receptor affinity |
| 09/07/2004 | US6787534 Sulfonamide-containing heterocyclic compounds |
| 09/07/2004 | US6787521 Skin disorders; kidney and liver disorders |
| 09/07/2004 | US6787151 Mixture of flavonoids, vegetable protein and sterols |
| 09/07/2004 | US6787141 Peptide having for fibrinogen fragment E activity, analogs, antibodies and uses thereof |
| 09/07/2004 | CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases |
| 09/02/2004 | WO2004074475A1 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same |
| 09/02/2004 | WO2004074288A1 Sulfonamide substituted xanthine derivatives for use as pepck inhibitors |
| 09/02/2004 | WO2004074256A1 Tetrahydroisoquinolinyl sulfamic acids |
| 09/02/2004 | WO2004074238A1 Phenethylamino sulfamic acids |
| 09/02/2004 | WO2004074236A1 Novel transcriptional factor, process for producing the same and use thereof |
| 09/02/2004 | WO2004073723A1 Medical drug containing fine particle of noble metal |
| 09/02/2004 | WO2004073722A1 Superoxide anion decomposing agent |
| 09/02/2004 | WO2004073611A2 Compounds for the treatment of metabolic disorders |
| 09/02/2004 | WO2004073593A2 Use of acylated aminopropanediols and sulphur and nitrogen analogues of same for different therapeutic applications |
| 09/02/2004 | WO2004073588A2 Diagnostics and therapeutics for diseases associated with g protein coupled receptor r35 (r35) |
| 09/02/2004 | WO2004058730A3 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 09/02/2004 | WO2004056324A3 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| 09/02/2004 | WO2004050635A3 Imidazol derivatives having affinity for alpha 2 receptors activity |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 09/02/2004 | WO2003099786A3 Aromatic sulfones and their medical use |
| 09/02/2004 | US20040171875 Process for the preparation of (r)- or (s)-aminocarnitine inner salt, the salts and derivatives thereof |
| 09/02/2004 | US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/02/2004 | US20040171835 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171793 Cyclic peptides as potent and selective melanocortin-4 receptors agonists |
| 09/02/2004 | US20040171695 Guanylhydrazones useful for treating diseases associated with T cell activation |
| 09/02/2004 | US20040171694 Inhibiting intestinal carbohydrate absorption without risk of diarrhea or dehydration |
| 09/02/2004 | US20040171690 Use of protein essential aminoacids to treat amenorrhea and related disorders |
| 09/02/2004 | US20040171680 Peroxisome proliferator activated receptor alpha modulators; such as 2-{6-[1-Ethyl-3-(4-trifluoromethoxyphenyl)ureido]-5,6,7,8-tetrahydronaphthalen-2-ylsulfanyl}-2-methylpropionic acid |
| 09/02/2004 | US20040171671 Cyclic ester of 3-hydroxybutyric acid; increasing cardiac efficiency, alternative glucose energy source, free radical scavenging |
| 09/02/2004 | US20040171663 Neuropathy, nephropathy, ophthalmopathy, arteriosclerosis; long lasting; single, low level daily dosage |
| 09/02/2004 | US20040171639 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 09/02/2004 | US20040171627 quinazolinone derivatives, especially halofuginone, can also inhibit the pathophysiological processes of renal fibrosis in vivo, including the effect on both the glomeruli and the tubuli interstitial compartments |
| 09/02/2004 | US20040171618 Compounds as PDE IV and TNF-inhibitors |
| 09/02/2004 | US20040171617 treatment for disorders and diseases, such as chronic inflammation, tissue breakdown and cancer |
| 09/02/2004 | US20040171607 Chemical compounds |
| 09/02/2004 | US20040171592 reduced gastric effects; salicylic acid derivatives |
| 09/02/2004 | US20040171590 Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents |
| 09/02/2004 | US20040171563 Novel use of tyrosine kinase inhibitor |
| 09/02/2004 | US20040171557 treating or educating said cells ex vivo in the presence of: intermediary metabolite; antigens or epitopes associated with said disease, or the immune-mediated inflammatory response; re-administering to said subject said treated or educated cells |
| 09/02/2004 | US20040171555 inhibitors of dipeptidyl peptidase; treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy and nephropathy and of sequelae of diabetes mellitus in mammals |
| 09/02/2004 | US20040171534 chimeric analogs include a hydrophobic moiety (tail), and can be prepared, either by anchoring one or several hydrophobic tails to the GRF, or by substituting one or several amino-acids by a pseudomicellar residue in the chemical synthesis of GRF |
| 09/02/2004 | US20040171530 Polypeptides containing cysteine and tryptophan |
| 09/02/2004 | US20040171528 Raise intracellular or extracellular or serum level of metabolite in subject |
| 09/02/2004 | US20040171527 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 09/02/2004 | US20040171526 Raise intracellular or extracellular or serum level of metabolite in subject |
| 09/02/2004 | US20040171522 Raise the intracellular or extracellular or serum level of metabolite in subject |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171117 Anti-RANK ligand monoclonal antibodies useful in treatment of RANK ligand mediated disorders |
| 09/02/2004 | US20040171073 Modulators which prevent lipid transport via blocking activity of scavenger receptors and for treating atheroscerotic disosrders; contraceptives |
| 09/02/2004 | US20040171018 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 09/02/2004 | US20040171012 Nucleic acid-associated proteins |
| 09/02/2004 | US20040170999 Nuclear hormone receptor ligand binding domain |
| 09/02/2004 | US20040170714 Bauhinia extracts |
| 09/02/2004 | US20040170713 To promote good health and as a dietary additive |
| 09/02/2004 | US20040170635 administering an inhibitor of the CD2/LFA-3 interaction, in combination with narrow band UVB radiation; especially for treating psoriasis |
| 09/02/2004 | US20040170620 Selected antibody compositions for binding to aminophospholipids |
| 09/02/2004 | US20040170618 antagonists bind to a recognized target (e.g., a receptor); the enzyme component of the chimera then degrades the target resulting in a reduction of activity of the target and release of the chimeric molecule, which is then free to attack and degrade another target molecule. |